ProShare Advisors LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,857
-11.3%
13,453
-0.1%
0.00%
Q2 2023$15,622
-14.6%
13,467
+11.2%
0.00%
Q1 2023$18,289
-44.8%
12,112
-8.5%
0.00%
Q4 2022$33,105
-31.0%
13,242
+16.7%
0.00%
Q3 2022$48,000
+50.0%
11,344
-1.9%
0.00%
Q2 2022$32,000
-67.7%
11,562
-33.3%
0.00%
Q1 2022$99,000
-46.2%
17,324
-14.0%
0.00%
Q4 2021$184,000
+44.9%
20,146
+70.2%
0.00%
Q3 2021$127,000
-65.9%
11,838
-50.6%
0.00%
-100.0%
Q2 2021$372,000
-2.1%
23,968
+2.4%
0.00%0.0%
Q1 2021$380,000
-7.5%
23,417
+20.6%
0.00%
-50.0%
Q4 2020$411,000
+158.5%
19,415
+80.7%
0.00%
+100.0%
Q3 2020$159,000
-9.1%
10,742
-9.8%
0.00%0.0%
Q2 2020$175,000
-34.7%
11,910
+4.5%
0.00%0.0%
Q4 2019$268,000
+0.4%
11,395
+35.1%
0.00%
-50.0%
Q3 2018$267,000
-18.1%
8,432
+0.3%
0.00%0.0%
Q2 2018$326,0008,4040.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders